Unbiased AI-powered news
8 stories related to this topic, newest first.
benzinga.comSpaceX submitted its S-1 registration statement for a planned NASDAQ listing expected to raise about $80 billion. The filing shows governance provisions that include dual-class shares and mandatory arbitration for shareholder disputes.
s31833.pcdn.coJohnson Fistel, PLLP announced an investigation into whether LiveRamp Holdings board members breached fiduciary duties regarding a proposed sale to Publicis Groupe. The inquiry follows LiveRamp's May 17 announcement of a definitive merger agreement.
benzinga.comThe Schall Law Firm announced an investigation into Atkore Inc. on May 17, 2026. The review examines whether the company breached fiduciary duties or issued misleading statements to shareholders.
newtraderu.comISS and Glass Lewis have recommended that shareholders of JP Morgan vote in favor of a resolution to separate the positions of chair and chief executive. The bank’s leader has held both roles since 2005 and 2006. Investors will vote on the proposal at the annual general meeting o…
Japan TimesSpaceX has put in place corporate governance policies that combine supervoting shares, mandatory arbitration and limits on shareholder proposals under Texas law. The structure will give its founder and CEO virtually unchecked executive authority and restrict investors' ability to…
rte.ieNational plaintiffs' law firm Berger Montague PC announced an investigation into Stryker Corporation's Board of Directors. The probe examines potential failures in oversight of cybersecurity and data protection practices following a recent cyber incident. Shareholders are advised…
indianexpress.comHalper Sadeh LLC announced an investigation into potential violations of federal securities laws and breaches of fiduciary duties related to several company transactions. The firm is examining deals involving Leggett & Platt, Avanos Medical, Select Medical Holdings, and Galera Th…
Substrate placeholder — needs reviewThe Schall Law Firm announced an investigation on April 22, 2026, into claims that ORIC Pharmaceuticals, Inc. violated securities laws through false or misleading statements. The probe targets disclosures related to investors. ORIC, which trades on NASDAQ under ORIC, recently ann…